Research output per year
Research output per year
Research activity per year
It is an honor and privilege to work at an institution such as Fox Chase Cancer Center which dedicates itself to personalized, comprehensive care of its patients. Treatment of cancer is a complicated process which involves the coordination of multiple teams. We are fortunate at Fox Chase Cancer Center to have robust treatment teams in every field of Oncology. I feel that a multidisciplinary team approach is absolutely critical to proper cancer treatment. Every patient is unique, and thus every treatment plan should be appropriately unique and individualized.
My treatment philosophy is centered on a simple ideology: how would I want my family to be treated? A new cancer diagnosis is undoubtedly scary and stressful. It is my goal during every patient visit to explain concepts thoroughly, create a comfortable environment where questions are answered, and participate in a shared decision-making strategy. I want every patient to leave the office confident knowing they have an entire team supporting them throughout their care and that they are active participants in how they are treated.
I received my medical degree from Robert Wood Johnson Medical School and completed my General Surgery training at Georgetown University in Washington, DC. During that time, I spent 2 additional years performing research at Memorial Sloan Kettering Cancer Center where I fostered skills I use today to design research protocols for diseases I treat. I then completed my Surgical Oncology training at Fox Chase Cancer Center where I am thrilled to currently practice.
I have dedicated training in minimally invasive and robotic surgical approaches to various cancer types and employ these techniques whenever safe and feasible. My practice is diverse and I treat a variety of cancers including stomach, small bowel, colon, rectal, liver, pancreas, skin, and soft tissue sarcoma. I am also actively involved in research to improve treatment in many of these diseases. I have developed active research protocols to help identify novel treatment approaches in rare cancers such as soft tissue sarcoma.
It is a true honor to treat cancer patients and I am proud to work at a center where compassion, teamwork, and innovation are embodied. It is my number one priority to ensure you receive the highest quality of care.
Appendix Cancer, Melanoma, Sarcoma, Liver, Gall Bladder & Bile Duct Cancer, Pancreatic Cancer, Stomach (Gastric) Cancer, Colorectal Cancer, Neuroendocrine Tumors, Skin Cancer
I have a particular interest in studying cancer outcomes across a wide variety of diseases. I leverage large datasets to study trends in treatment, disparities in access and implementation of care, and effects of novel treatment strategies. These studies aim to inform the basis of policy change or future trials to test novel therapeutic strategies which may improve cancer outcomes.
My translational research focuses on the study of retroperitoneal soft tissue sarcoma, an extremely rare disease in which large tumors arise in the abdomen. Owing to their rarity, very little is known about their underlying biology and there are few effective treatment options. I created and implemented a research protocol which studies why these tumors develop and looks to identify novel therapeutic strategies for treatment.
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
05/14/25
1 item of Media coverage
Press/Media
05/13/25
4 items of Media coverage
Press/Media